General Bill
International Drug Reference Pricing:
Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc.
Effective Date:
07/01/2024
Last Event:
03/08/24 S Died in Health Policy on Friday, March 8, 2024 2:25 PM
-
Health Policy
-
Appropriations Committee on Health and Human Services
-
Fiscal Policy
| Bill #
|
Subject
|
Relationship
|
|
Bill #:
HB 1431
|
Subject:
International Drug Reference Pricing
|
Relationship:
Similar
|
| Event |
Time |
Member |
Committee |
Ver. |
|
Event:
S Died in Health Policy
|
Time:
03/08/2024 - 2:25 PM
|
Member:
|
Committee:
Health Policy
|
Version:
__
|
|
Event:
S Introduced
|
Time:
01/11/2024 - 4:57 PM
|
Member:
|
Committee:
|
Version:
__
|
|
Event:
S Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
|
Time:
01/11/2024 - 7:56 AM
|
Member:
|
Committee:
Health Policy
|
Version:
__
|
|
Event:
S Filed
|
Time:
01/05/2024 - 7:59 PM
|
Member:
|
Committee:
|
Version:
__
|